Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Porat

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Pharmaceutics|December 23, 2023
The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/BypassDaniel Porat, Oleg Dukhno, Sandra Cvijić, et al.
Drug Delivery and Translational Research|December 3, 2019
Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategiesShimon Ben-Shabat, Ludmila Yarmolinsky, Daniel Porat, et al.
Molecular Pharmaceutics|June 27, 2022
Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric SurgeryDaniel Porat, Oleg Dukhno, Ella Vainer, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 2, 2019
Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effectsCarmil Azran, Daniel Porat, Noa Fine-Shamir, et al.
Pharmaceutics|November 27, 2021
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of MetforminArik Dahan, Daniel Porat, Milica Markovic, et al.
International Journal of Pharmaceutics|August 26, 2023
Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokineticsDaniel Porat, Oleg Dukhno, Mazal Partook-Maccabi, et al.
Obesity Surgery|November 19, 2018
Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the LiteratureArik Dahan, Daniel Porat, Carmil Azran, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 30, 2017
Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposideAvital Beig, Noa Fine-Shamir, Daniel Porat, et al.
Journal of Pharmaceutical Sciences|July 29, 2018
Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability ValuesOmri Wolk, Milica Markovic, Daniel Porat, et al.
Pharmaceutics|July 27, 2022
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of MinoxidilMilica Markovic, Moran Zur, Sapir Garsiani, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmaceutics|December 23, 2023
The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/BypassDaniel Porat, Oleg Dukhno, Sandra Cvijić, et al.
Drug Delivery and Translational Research|December 3, 2019
Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategiesShimon Ben-Shabat, Ludmila Yarmolinsky, Daniel Porat, et al.
Molecular Pharmaceutics|June 27, 2022
Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric SurgeryDaniel Porat, Oleg Dukhno, Ella Vainer, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 2, 2019
Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effectsCarmil Azran, Daniel Porat, Noa Fine-Shamir, et al.
Pharmaceutics|November 27, 2021
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of MetforminArik Dahan, Daniel Porat, Milica Markovic, et al.
International Journal of Pharmaceutics|August 26, 2023
Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokineticsDaniel Porat, Oleg Dukhno, Mazal Partook-Maccabi, et al.
Obesity Surgery|November 19, 2018
Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the LiteratureArik Dahan, Daniel Porat, Carmil Azran, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 30, 2017
Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposideAvital Beig, Noa Fine-Shamir, Daniel Porat, et al.
Journal of Pharmaceutical Sciences|July 29, 2018
Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability ValuesOmri Wolk, Milica Markovic, Daniel Porat, et al.
Pharmaceutics|July 27, 2022
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of MinoxidilMilica Markovic, Moran Zur, Sapir Garsiani, et al.
Pageof 3